About Us Services Careers FAQ Contact Us 0
Home Medical Devices Oncology Companion Diagnostics Market Size & Share Report 2031
Oncology Companion Diagnostics Market

Oncology Companion Diagnostics Market Size, Share & Trends Analysis Report By Product and Service (Product, Equipment , Reagents and Consumables, Software/Analysis Tools, Service), By Technology (PCR, ISH, Immunohistochemistry, Sequencing, Microarrays, Imaging Technologies, Other Technologies), By Tumor Type (Benign Tumor, Malignant Tumor), By Type (Next Generation Cancer Diagnostics, Oncology Companion Diagnostics) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRMD54776DR
Last Updated : July 28, 2023
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Oncology Companion Diagnostics Market Introduction
    2. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Product
        1. By Value
      3. Equipment 
        1. By Value
      4. Reagents and Consumables
        1. By Value
      5. Software/Analysis Tools
        1. By Value
      6. Service
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. ISH
        1. By Value
      4. Immunohistochemistry
        1. By Value
      5. Sequencing
        1. By Value
      6. Microarrays
        1. By Value
      7. Imaging Technologies
        1. By Value
      8. Other Technologies
        1. By Value
    4. By Tumor Type
      1. Introduction
        1. Tumor Type By Value
      2. Benign Tumor
        1. By Value
      3. Malignant Tumor
        1. By Value
    5. By Type
      1. Introduction
        1. Type By Value
      2. Next Generation Cancer Diagnostics
        1. By Value
      3. Oncology Companion Diagnostics
        1. By Value
    1. Introduction
    2. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Product
        1. By Value
      3. Equipment 
        1. By Value
      4. Reagents and Consumables
        1. By Value
      5. Software/Analysis Tools
        1. By Value
      6. Service
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. ISH
        1. By Value
      4. Immunohistochemistry
        1. By Value
      5. Sequencing
        1. By Value
      6. Microarrays
        1. By Value
      7. Imaging Technologies
        1. By Value
      8. Other Technologies
        1. By Value
    4. By Tumor Type
      1. Introduction
        1. Tumor Type By Value
      2. Benign Tumor
        1. By Value
      3. Malignant Tumor
        1. By Value
    5. By Type
      1. Introduction
        1. Type By Value
      2. Next Generation Cancer Diagnostics
        1. By Value
      3. Oncology Companion Diagnostics
        1. By Value
    6. U.S.
      1. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Product
          1. By Value
        3. Equipment 
          1. By Value
        4. Reagents and Consumables
          1. By Value
        5. Software/Analysis Tools
          1. By Value
        6. Service
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. ISH
          1. By Value
        4. Immunohistochemistry
          1. By Value
        5. Sequencing
          1. By Value
        6. Microarrays
          1. By Value
        7. Imaging Technologies
          1. By Value
        8. Other Technologies
          1. By Value
      3. By Tumor Type
        1. Introduction
          1. Tumor Type By Value
        2. Benign Tumor
          1. By Value
        3. Malignant Tumor
          1. By Value
      4. By Type
        1. Introduction
          1. Type By Value
        2. Next Generation Cancer Diagnostics
          1. By Value
        3. Oncology Companion Diagnostics
          1. By Value
    7. Canada
    1. Introduction
    2. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Product
        1. By Value
      3. Equipment 
        1. By Value
      4. Reagents and Consumables
        1. By Value
      5. Software/Analysis Tools
        1. By Value
      6. Service
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. ISH
        1. By Value
      4. Immunohistochemistry
        1. By Value
      5. Sequencing
        1. By Value
      6. Microarrays
        1. By Value
      7. Imaging Technologies
        1. By Value
      8. Other Technologies
        1. By Value
    4. By Tumor Type
      1. Introduction
        1. Tumor Type By Value
      2. Benign Tumor
        1. By Value
      3. Malignant Tumor
        1. By Value
    5. By Type
      1. Introduction
        1. Type By Value
      2. Next Generation Cancer Diagnostics
        1. By Value
      3. Oncology Companion Diagnostics
        1. By Value
    6. U.K.
      1. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Product
          1. By Value
        3. Equipment 
          1. By Value
        4. Reagents and Consumables
          1. By Value
        5. Software/Analysis Tools
          1. By Value
        6. Service
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. ISH
          1. By Value
        4. Immunohistochemistry
          1. By Value
        5. Sequencing
          1. By Value
        6. Microarrays
          1. By Value
        7. Imaging Technologies
          1. By Value
        8. Other Technologies
          1. By Value
      3. By Tumor Type
        1. Introduction
          1. Tumor Type By Value
        2. Benign Tumor
          1. By Value
        3. Malignant Tumor
          1. By Value
      4. By Type
        1. Introduction
          1. Type By Value
        2. Next Generation Cancer Diagnostics
          1. By Value
        3. Oncology Companion Diagnostics
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Product
        1. By Value
      3. Equipment 
        1. By Value
      4. Reagents and Consumables
        1. By Value
      5. Software/Analysis Tools
        1. By Value
      6. Service
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. ISH
        1. By Value
      4. Immunohistochemistry
        1. By Value
      5. Sequencing
        1. By Value
      6. Microarrays
        1. By Value
      7. Imaging Technologies
        1. By Value
      8. Other Technologies
        1. By Value
    4. By Tumor Type
      1. Introduction
        1. Tumor Type By Value
      2. Benign Tumor
        1. By Value
      3. Malignant Tumor
        1. By Value
    5. By Type
      1. Introduction
        1. Type By Value
      2. Next Generation Cancer Diagnostics
        1. By Value
      3. Oncology Companion Diagnostics
        1. By Value
    6. China
      1. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Product
          1. By Value
        3. Equipment 
          1. By Value
        4. Reagents and Consumables
          1. By Value
        5. Software/Analysis Tools
          1. By Value
        6. Service
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. ISH
          1. By Value
        4. Immunohistochemistry
          1. By Value
        5. Sequencing
          1. By Value
        6. Microarrays
          1. By Value
        7. Imaging Technologies
          1. By Value
        8. Other Technologies
          1. By Value
      3. By Tumor Type
        1. Introduction
          1. Tumor Type By Value
        2. Benign Tumor
          1. By Value
        3. Malignant Tumor
          1. By Value
      4. By Type
        1. Introduction
          1. Type By Value
        2. Next Generation Cancer Diagnostics
          1. By Value
        3. Oncology Companion Diagnostics
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Product
        1. By Value
      3. Equipment 
        1. By Value
      4. Reagents and Consumables
        1. By Value
      5. Software/Analysis Tools
        1. By Value
      6. Service
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. ISH
        1. By Value
      4. Immunohistochemistry
        1. By Value
      5. Sequencing
        1. By Value
      6. Microarrays
        1. By Value
      7. Imaging Technologies
        1. By Value
      8. Other Technologies
        1. By Value
    4. By Tumor Type
      1. Introduction
        1. Tumor Type By Value
      2. Benign Tumor
        1. By Value
      3. Malignant Tumor
        1. By Value
    5. By Type
      1. Introduction
        1. Type By Value
      2. Next Generation Cancer Diagnostics
        1. By Value
      3. Oncology Companion Diagnostics
        1. By Value
    6. UAE
      1. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Product
          1. By Value
        3. Equipment 
          1. By Value
        4. Reagents and Consumables
          1. By Value
        5. Software/Analysis Tools
          1. By Value
        6. Service
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. ISH
          1. By Value
        4. Immunohistochemistry
          1. By Value
        5. Sequencing
          1. By Value
        6. Microarrays
          1. By Value
        7. Imaging Technologies
          1. By Value
        8. Other Technologies
          1. By Value
      3. By Tumor Type
        1. Introduction
          1. Tumor Type By Value
        2. Benign Tumor
          1. By Value
        3. Malignant Tumor
          1. By Value
      4. By Type
        1. Introduction
          1. Type By Value
        2. Next Generation Cancer Diagnostics
          1. By Value
        3. Oncology Companion Diagnostics
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Product and Service
      1. Introduction
        1. Product and Service By Value
      2. Product
        1. By Value
      3. Equipment 
        1. By Value
      4. Reagents and Consumables
        1. By Value
      5. Software/Analysis Tools
        1. By Value
      6. Service
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. ISH
        1. By Value
      4. Immunohistochemistry
        1. By Value
      5. Sequencing
        1. By Value
      6. Microarrays
        1. By Value
      7. Imaging Technologies
        1. By Value
      8. Other Technologies
        1. By Value
    4. By Tumor Type
      1. Introduction
        1. Tumor Type By Value
      2. Benign Tumor
        1. By Value
      3. Malignant Tumor
        1. By Value
    5. By Type
      1. Introduction
        1. Type By Value
      2. Next Generation Cancer Diagnostics
        1. By Value
      3. Oncology Companion Diagnostics
        1. By Value
    6. Brazil
      1. By Product and Service
        1. Introduction
          1. Product and Service By Value
        2. Product
          1. By Value
        3. Equipment 
          1. By Value
        4. Reagents and Consumables
          1. By Value
        5. Software/Analysis Tools
          1. By Value
        6. Service
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. ISH
          1. By Value
        4. Immunohistochemistry
          1. By Value
        5. Sequencing
          1. By Value
        6. Microarrays
          1. By Value
        7. Imaging Technologies
          1. By Value
        8. Other Technologies
          1. By Value
      3. By Tumor Type
        1. Introduction
          1. Tumor Type By Value
        2. Benign Tumor
          1. By Value
        3. Malignant Tumor
          1. By Value
      4. By Type
        1. Introduction
          1. Type By Value
        2. Next Generation Cancer Diagnostics
          1. By Value
        3. Oncology Companion Diagnostics
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Oncology Companion Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Agilent Technologies Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Illumina Inc.
    3. Thermo Fisher Scientific Inc.
    4. F. Hoffmann-La Roche Ltd.
    5. QIAGEN N.V.
    6. ARUP Laboratories
    7. Myriad Genetics Inc.
    8. Abbott
    9. bioMérieux SA
    10. Invivoscribe Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global companion diagnostics market size was valued at USD 5.37 billion in 2023. It is estimated to reach USD 15.87 billion by 2032, growing at a CAGR of 12.8% during the forecast period (2024–2032). The growing prevalence of chronic diseas
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.